CMS’ Legal Justification Of Gender Affirming Care Ban Could Place Other Medications At Risk

 
• By Sarah Karlin-Smith
  
CMS Administrator Oz
CMS Administrator Mehmet Oz spoke about new proposed rules to limit gender affirming care on Dec. 18 (HHS)

More from Market Access

More from United States